These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Modern management of acne. Cooper AJ; Harris VR Med J Aust; 2017 Jan; 206(1):41-45. PubMed ID: 28076744 [TBL] [Abstract][Full Text] [Related]
26. Dapsone 5% gel: a review of its efficacy and safety in the treatment of acne vulgaris. Stotland M; Shalita AR; Kissling RF Am J Clin Dermatol; 2009; 10(4):221-7. PubMed ID: 19489655 [TBL] [Abstract][Full Text] [Related]
27. Phototherapy in the treatment of acne vulgaris. Sami NA; Attia AT; Badawi AM J Drugs Dermatol; 2008 Jul; 7(7):627-32. PubMed ID: 18664153 [TBL] [Abstract][Full Text] [Related]
28. Procedural treatments for acne vulgaris. Taub AF Dermatol Surg; 2007 Sep; 33(9):1005-26. PubMed ID: 17760592 [TBL] [Abstract][Full Text] [Related]
31. Dapsone 7.5% Gel: A Review in Acne Vulgaris. Al-Salama ZT; Deeks ED Am J Clin Dermatol; 2017 Feb; 18(1):139-145. PubMed ID: 28005194 [TBL] [Abstract][Full Text] [Related]
32. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females. Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500141 [TBL] [Abstract][Full Text] [Related]
33. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females. Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500140 [TBL] [Abstract][Full Text] [Related]
34. Once-Daily Topical Dapsone Gel, 7.5%: Effective for Acne Vulgaris Regardless of Baseline Lesion Count, With Superior Efficacy in Females. Tanghetti E; Harper J; Baldwin H; Kircik L; Bai Z; Alvandi N J Drugs Dermatol; 2018 Nov; 17(11):1192-1198. PubMed ID: 30500139 [TBL] [Abstract][Full Text] [Related]
35. The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable. Tanghetti E; Harper JC; Oefelein MG J Drugs Dermatol; 2012 Dec; 11(12):1417-21. PubMed ID: 23377510 [TBL] [Abstract][Full Text] [Related]
36. [Photodynamic therapy--moving under the right light]. Hönigsmann H J Dtsch Dermatol Ges; 2004 Dec; 2(12):981-2. PubMed ID: 16285310 [No Abstract] [Full Text] [Related]
37. Clinical considerations on the use of concomitant therapy in the treatment of acne. Alexis AF J Dermatolog Treat; 2008; 19(4):199-209. PubMed ID: 18608730 [TBL] [Abstract][Full Text] [Related]
38. A review on the treatment of acne vulgaris. Layton AM Int J Clin Pract; 2006 Jan; 60(1):64-72. PubMed ID: 16409430 [TBL] [Abstract][Full Text] [Related]
39. Topical antimicrobial treatment of acne vulgaris: an evidence-based review. Gamble R; Dunn J; Dawson A; Petersen B; McLaughlin L; Small A; Kindle S; Dellavalle RP Am J Clin Dermatol; 2012 Jun; 13(3):141-52. PubMed ID: 22268388 [TBL] [Abstract][Full Text] [Related]
40. Guidelines of care for acne vulgaris management. Strauss JS; Krowchuk DP; Leyden JJ; Lucky AW; Shalita AR; Siegfried EC; Thiboutot DM; Van Voorhees AS; Beutner KA; Sieck CK; Bhushan R; J Am Acad Dermatol; 2007 Apr; 56(4):651-63. PubMed ID: 17276540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]